Literature DB >> 11716041

Computer-assisted cell morphometry and ploidy analysis in the assessment of thyroid follicular neoplasms.

A Frasoldati1, M Flora, M Pesenti, A Caroggio, R Valcavil.   

Abstract

Conventional cytology cannot discriminate between benign and malignant follicular neoplasms. Our study evaluated the diagnostic role of computer-assisted image analysis in the presurgical assessment of thyroid follicular neoplasms. Fifty-eight patients (14 males, 44 females, age range, 45-75 years) who underwent surgery for cytologic diagnosis of thyroid follicular neoplasm were studied. All patients were first evaluated on clinical grounds and assigned a high/low suspicion of malignancy on the basis of gender, age, and nodule size. Cell image analysis was subsequently performed using a Cytometrica BYK Gulden microscope image processor on Feulgen-stained thyroid cytologic smears. A different population of 50 benign and 50 malignant, histologically evaluated nodules was studied in order to establish image analysis criteria suggestive of thyroid malignancy. Ploidy histogram, proliferation index (PI), nuclear area coefficient of variation (NACV), and anisocariosis ratio (AR) were studied. Thyroid cancer was diagnosed in 16 of 58 follicular neoplasms. Only 7 of these lesions were clinically suspicious (43.7%), whereas 14 of 16 (87.5%) malignant tumors were identified by image analysis. Positive and negative predictive values of image analysis versus clinical evaluation were 46.6% versus 30.4% and 92.8% versus 74.3%, respectively. The distribution of ploidy pattern was different in benign versus malignant follicular neoplasms (chi2 8.25, p = 0.016), malignant lesions showing an increased frequency of heteroclonal aneuploid DNA content (37.5% vs. 7.1%). Increased PI (mean +/- standard deviation (SD) = 11.3 +/- 5.7 vs. 7.1 +/- 6.1; p < 0.01) and NACV (mean +/- SD = 25.28 +/- 1.89 vs. 20.14 0.91; p < 0.01) levels were also observed in malignant follicular neoplasms. In conclusion, computer-assisted image analysis may profitably support clinical evaluation in the assessment of thyroid follicular neoplasms.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11716041     DOI: 10.1089/105072501753211000

Source DB:  PubMed          Journal:  Thyroid        ISSN: 1050-7256            Impact factor:   6.568


  6 in total

1.  An optimal transportation approach for nuclear structure-based pathology.

Authors:  Wei Wang; John A Ozolek; Dejan Slepčev; Ann B Lee; Cheng Chen; Gustavo K Rohde
Journal:  IEEE Trans Med Imaging       Date:  2010-10-25       Impact factor: 10.048

2.  Detection and classification of thyroid follicular lesions based on nuclear structure from histopathology images.

Authors:  Wei Wang; John A Ozolek; Gustavo K Rohde
Journal:  Cytometry A       Date:  2010-05       Impact factor: 4.355

3.  Accurate diagnosis of thyroid follicular lesions from nuclear morphology using supervised learning.

Authors:  John A Ozolek; Akif Burak Tosun; Wei Wang; Cheng Chen; Soheil Kolouri; Saurav Basu; Hu Huang; Gustavo K Rohde
Journal:  Med Image Anal       Date:  2014-04-21       Impact factor: 8.545

4.  Computerized nuclear morphometry in the diagnosis of thyroid lesions with predominant follicular pattern.

Authors:  Ha Aiad; Ag Abdou; Ma Bashandy; An Said; Ss Ezz-Elarab; Aa Zahran
Journal:  Ecancermedicalscience       Date:  2009-09-17

5.  Follicular thyroid lesions: is there a discriminatory potential in the computerized nuclear analysis?

Authors:  Flávia O Valentim; Bárbara P Coelho; Hélio A Miot; Caroline Y Hayashi; Danilo T A Jaune; Cristiano C Oliveira; Mariângela E A Marques; José Vicente Tagliarini; Emanuel C Castilho; Paula Soares; Gláucia M F S Mazeto
Journal:  Endocr Connect       Date:  2018-07-04       Impact factor: 3.335

6.  Postoperative findings and risk for malignancy in thyroid nodules with cytological diagnosis of the so-called "follicular neoplasm".

Authors:  Eun Sook Kim; Il Seong Nam-Goong; Gyungyub Gong; Suck Joon Hong; Won Bae Kim; Young Kee Shong
Journal:  Korean J Intern Med       Date:  2003-06       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.